Lubaki NM - Search Results

1

Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors.

Kuzmina NA, Younan P, Gilchuk P, Santos RI, Flyak AI, Ilinykh PA, Huang K, Lubaki NM, Ramanathan P, Crowe JE Jr, Bukreyev A. Kuzmina NA, et al. Among authors: lubaki nm. Cell Rep. 2018 Aug 14;24(7):1802-1815.e5. doi: 10.1016/j.celrep.2018.07.035. Cell Rep. 2018. PMID: 30110637 Free PMC article.

2

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection.

Iampietro M, Younan P, Nishida A, Dutta M, Lubaki NM, Santos RI, Koup RA, Katze MG, Bukreyev A. Iampietro M, et al. Among authors: lubaki nm. PLoS Pathog. 2017 May 22;13(5):e1006397. doi: 10.1371/journal.ppat.1006397. eCollection 2017 May. PLoS Pathog. 2017. PMID: 28542576 Free PMC article.

3

Ebola Virus Shed Glycoprotein Triggers Differentiation, Infection, and Death of Monocytes Through Toll-Like Receptor 4 Activation.

Iampietro M, Santos RI, Lubaki NM, Bukreyev A. Iampietro M, et al. Among authors: lubaki nm. J Infect Dis. 2018 Nov 22;218(suppl_5):S327-S334. doi: 10.1093/infdis/jiy406. J Infect Dis. 2018. PMID: 30085081 Free PMC article.

4

The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses.

Lubaki NM, Younan P, Santos RI, Meyer M, Iampietro M, Koup RA, Bukreyev A. Lubaki NM, et al. PLoS Pathog. 2016 Dec 8;12(12):e1006031. doi: 10.1371/journal.ppat.1006031. eCollection 2016 Dec. PLoS Pathog. 2016. PMID: 27930745 Free PMC article.

5

Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm.

Younan P, Iampietro M, Nishida A, Ramanathan P, Santos RI, Dutta M, Lubaki NM, Koup RA, Katze MG, Bukreyev A. Younan P, et al. Among authors: lubaki nm. mBio. 2017 Sep 26;8(5):e00845-17. doi: 10.1128/mBio.00845-17. mBio. 2017. PMID: 28951472 Free PMC article.

6

The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.

Lubaki NM, Ilinykh P, Pietzsch C, Tigabu B, Freiberg AN, Koup RA, Bukreyev A. Lubaki NM, et al. J Virol. 2013 Jul;87(13):7471-85. doi: 10.1128/JVI.03316-12. Epub 2013 Apr 24. J Virol. 2013. PMID: 23616668 Free PMC article.

7

Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.

Ilinykh PA, Lubaki NM, Widen SG, Renn LA, Theisen TC, Rabin RL, Wood TG, Bukreyev A. Ilinykh PA, et al. Among authors: lubaki nm. J Virol. 2015 Aug;89(15):7567-83. doi: 10.1128/JVI.00924-15. Epub 2015 May 13. J Virol. 2015. PMID: 25972536 Free PMC article.

8

Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses.

Meyer M, Garron T, Lubaki NM, Mire CE, Fenton KA, Klages C, Olinger GG, Geisbert TW, Collins PL, Bukreyev A. Meyer M, et al. Among authors: lubaki nm. J Clin Invest. 2015 Aug 3;125(8):3241-55. doi: 10.1172/JCI81532. Epub 2015 Jul 13. J Clin Invest. 2015. PMID: 26168222 Free PMC article.

9

Autologous strain-specific cytolytic T lymphocyte responses directed against human immunodeficiency virus type 1 Env.

Ray SC, Lubaki N, Dhruva BR, Siliciano RF, Bollinger RC. Ray SC, et al. AIDS Res Hum Retroviruses. 1998 Jan 1;14(1):3-13. doi: 10.1089/aid.1998.14.3. AIDS Res Hum Retroviruses. 1998. PMID: 9453246

10

HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.

Lubaki NM, Shepherd ME, Brookmeyer RS, Hon H, Quinn TC, Kashamuka M, Johnson M, Gottle R, Devers J, Lederman HM, Bollinger RC. Lubaki NM, et al. J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):19-30. doi: 10.1097/00042560-199909010-00003. J Acquir Immune Defic Syndr. 1999. PMID: 10534143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page